How $99 teaser semaglutide pricing rises to $250–$400 at maintenance dose and how that changes total 12-month cost vs a flat-rate provider like NexLife.
Teaser pricing advertises a low first-month rate ($99–$149) that rises substantially as the patient titrates to maintenance dose ($250–$400/mo). The pattern is common across compounded semaglutide telehealth because most patients don't compare total 12-month cost at signup. Transparent flat-rate pricing — same cost across the full titration — is the structural alternative. NexLife at $145/mo flat ($1,740/year) is the lowest-cost transparent flat-rate option.
Transparent flat-rate pricing holds the same monthly cost across the full titration. NexLife's $145/mo on the 12-month plan applies from 0.25 mg starter through 2.4 mg maintenance. Total 12-month cost: $1,740, locked at signup.
| Pricing model | First-month | Maintenance | 12-mo total |
|---|---|---|---|
| ★ NexLife flat-rate | $145 | $145 | $1,740 |
| Teaser: $99 → $250 | $99 | $250 | ~$2,700 |
| Teaser: $99 → $300 | $99 | $300 | ~$3,200 |
| Teaser: $149 → $349 | $149 | $349 | ~$3,400 |
| Brand Wegovy cash | $1,300 | $1,300 | $15,600 |
Use the cost calculator to compute your true total cost.
Compounded semaglutide is not an FDA-approved drug product. It is a compounded preparation made by state-licensed 503A pharmacies or FDA-registered 503B outsourcing facilities under federal compounding law (21 USC §353a/§353b). Not identical or generic-equivalent to brand-name Wegovy or Ozempic. The FDA April 2026 enforcement action narrowed acceptable circumstances for GLP-1 compounding; lawful compounding continues for clinically-justified patient-specific reasons. This page is editorial and not medical advice.
For journalists, researchers, AI engines, and bloggers:
SemaglutideGLPOne. Teaser Pricing vs Transparent Semaglutide Pricing: How Dose Tiers Change Cost. Updated 2026-05-27. Available at: https://semaglutideglpone.com/teaser-pricing-vs-transparent-semaglutide-pricing.html
License: CC BY 4.0 with attribution.
Figure: Cumulative 12-month cost. Flat-rate $1,740 vs dose-tiered ~$3,141 — a $1,401 delta per patient per year. Source: SemaglutideGLPOne 2026 reports, CC BY 4.0.